| Date | Ref. No. | Patent No. | Title |
| 5/10/2013 | E-053-2013/0 | | A Diagnostic Kit for Assessing Exposure or Infection by the Koala Family of Retroviruses |
| 5/7/2013 | E-011-2010/0
E-266-2000/0
E-286-1988/1
E-286-1988/2 | 5,827,647
5,916,563
6,001,371
6,132,732
6,558,676 | Parvovirus B19 Vaccine |
| 4/17/2013 | E-067-2011/0 | | Improved Standard for Immune System Recovery Assay |
| 3/21/2013 | E-074-2011/2 | | Infectious Hepatitis E Virus Genotype 3 Recombinants – Prospective Vaccine Candidates and Vector System |
| 3/18/2013 | E-273-2011/0 | | Cross-Reactive Dengue Fully Human Monoclonal Antibodies |
| 3/18/2013 | E-217-2011/0 | | Novel Diagnostic Marker for Prediction of Clearance of Hepatitis C Virus Infection |
| 3/18/2013 | E-217-2011/1 | | Novel Host Target for Treatment of Hepatitis C Virus Infection |
| 2/15/2013 | E-127-2007/0 | | Improved Bacterial Host for Production of Anthrax Toxin Proteins and Vaccines: Bacillus anthracis BH450 |
| 2/14/2013 | E-283-2003/0 | | Enzymatically-Active RNA-Dependent RNA Polymerase From a Human Norovirus (Calicivirus) |
| 2/14/2013 | E-214-2003/0 | | Construction of an Infectious Full-Length cDNA Clone of the Porcine Enteric Calicivirus RNA Genome |
| 2/14/2013 | E-198-2003/0 | | Construction of Recombinant Baculoviruses Carrying the Gene Encoding the Major Capsid Protein, VP1, From Calicivirus Strains (Including Norovirus Strains Toronto, Hawaii, Desert Shield, Snow Mountain, and MD145-12) |
| 2/5/2013 | E-002-2012/0
E-167-2012/0 | | Therapeutic Hepatitis C Virus Antibodies |
| 1/11/2013 | E-222-2012/0 | | Transmission-Blocking Malaria Vaccine |
| 9/12/2012 | E-042-2008/0 | | Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studies |
| 8/31/2012 | E-078-2009/0 | | Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses |
| 8/17/2012 | E-222-2010/1 | | Filovirus Vaccines and Diagnostics Based on Glycoprotein-Fc Fusion Proteins |
| 8/1/2012 | E-194-2005/0 | 7,871,777 | The Medusa™ Sequencer: A DNA or RNA Sequencing Machine the Size of a Molecule |
| 7/31/2012 | E-174-2005/0 | 8263360 | Novel Infrared (IR)-Transparent Hydrophilic Membrane That Can be Used for Filtration, Printing or Microarrays, and Cultivation of Bacteria and Other Microorganisms for Reagent-Free IR Spectroscopic Identification |
| 7/31/2012 | E-259-2004/2
E-259-2004/3 | 7,888,003 | HIV-1 Infection Detection Assay for Seroconverted HIV-1 Vaccine Recipients |
| 5/25/2012 | E-036-2010/1 | | Simple, Quantitative Sensitive High-throughput Antibody Detection for Lyme Disease |
| 4/30/2012 | E-011-2010/0 | | Parvovirus B19 Codon Optimized Structural Proteins for Vaccine and Diagnostic Applications |
| 4/30/2012 | E-093-2010/0 | | Diagnostic H5N1 Avian Influenza Virus Peptides |
| 3/3/2012 | E-032-2010/1 | | Bacterially Expressed Influenza Virus Recombinant HA Proteins for Vaccine and Diagnostic Applications |
| 2/21/2012 | E-271-2011/0 | | Influenza Vaccine |
| 1/18/2012 | E-188-2006/0 | | Method for Producing Significant Amounts of B19 Virus for Development of Killed or Attenuated Vaccines |
| 1/11/2012 | E-076-1992/0 | | Clones Encoding Mammalian ADP-Ribosylarginine Hydrolases |
| 1/9/2012 | E-153-2006/0 | | Immunogenic Tetrasaccharide of Anthrax Spores |
| 9/29/2011 | E-231-2011/0 | | Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV) |
| 9/29/2011 | E-281-2010/0 | | Diagnostic Assays and Methods of Use for Detection of Filarial Infection |
| 8/30/2011 | E-308-2008/0 | | A Vaccine for Shigella sonnei for Both Children and Adults |
| 8/12/2011 | E-076-2011/0 | | Monoclonal Antibodies Against Poliovirus |
| 8/2/2011 | E-056-2007/0 | 8,017,938 | Microarray Binding Sensors Using Carbon Nanotube Transistors |
| 7/26/2011 | E-032-2011/0 | | Multivalent Vaccines for Rabies Virus and Filoviruses |
| 2/28/2011 | E-049-2004/0 | 7,303,751 | Anti-Plasmodium Compositions and Methods of Use |
| 2/28/2011 | E-003-1989/0 | 5,869,608
6,384,206 | Nucleotide And Amino Acid Sequences Of The Four Variable Domains Of The Major Outer Membrane Proteins Of Chlamydia Trachomatis |
| 2/28/2011 | E-139-2006/0 | 8,337,860 | Development of Dengue Virus Type 3 Vaccine Candidates |
| 2/28/2011 | E-240-2007/0 | | Development of Antigenic Chimeric St. Louis Encephalitis Virus/Dengue Virus Type Four Recombinant Viruses (SLEV/DEN4) as Vaccine Candidates for the Prevention of Disease Caused by SLEV |
| 2/28/2011 | E-031-2006/0 | | Chlamydia Vaccine |
| 2/28/2011 | E-066-2003/5 | 7,622,113
8,337,853 | Monoclonal Antibodies That Bind or Neutralize Dengue Virus |
| 2/28/2011 | E-004-2004/2 | 20042011615
7,025,961 | Anti-Plasmodium Compositions and Methods of Use |
| 2/28/2011 | E-022-2004/0 | 7,851,194 | Live-Attenuated West Nile Virus Vaccines with Improved Immune Responses |
| 2/28/2011 | E-089-2002/1 | 7,517,531
8,075,903 | Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4 |
| 2/28/2011 | E-130-2002/0
E-189-2008/2
E-285-2002/0 | 7,485,306
7,741,437 | Vaccines Comprising Sand Fly Salivary Proteins for Control of Leishmania Infection |
| 10/29/2010 | E-156-2008/0 | | Insertion of Foreign Genes in Rubella Virus and their Stable Expression in a Live, Attenuated Viral Vaccine |
| 7/2/2010 | E-039-1999/0 | 7,115,262
8,420,099 | A Novel Chimeric Bifunctional Protein for Prevention and Treatment of HIV Infection |
| 6/14/2010 | E-236-2007/3 | | Immunogenic Peptides Against Influenza Virus |
| 6/14/2010 | E-142-2008/0 | | Humanized Monoclonal Antibodies that Specifically Bind Japanese Encephalitis Virus (JEV) and Their Use |
| 6/14/2010 | E-317-2001/0 | | Discovery of Novel Inhibitors of HIV-1 Integrase That Can Be Used for the Treatment of Retroviral Infection Including AIDS |
| 6/14/2010 | E-230-2002/2 | 7,482,133 | Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use |
| 6/14/2010 | E-189-1998/0 | | Inhibitors of Formation of Protease Resistant Prion Protein |
| 6/14/2010 | E-247-2002/1 | | Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis) |
| 6/10/2010 | E-008-1996/0 | | C-C Chemokines That Inhibit Retrovirus Infection |
| 6/3/2010 | E-152-2009/0 | | qPCR Assay for Detection of JC Virus |
| 2/12/2010 | E-279-2007/0 | 8,425,901 | Alpha 1-3 N-Acetylgalactosaminyltransferases with Altered Donor and Acceptor Specificities, Compositions, and Methods of Use: Development of Pharmaceutical Agents and Improved Vaccines |
| 2/12/2010 | E-280-2007/0 | | Beta 1,4-Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use: Development of Pharmaceuticals and Improved Vaccines |
| 10/7/2009 | E-328-2001/1 | 8,466,116 | Use of CpG Oligodeoxynucleotides to Induce Epithelial Cell Growth |
| 9/3/2009 | E-169-2004/0
E-281-2005/0
E-318-2000/0 | | Rapid Diagnostic Applications of Phage |
| 8/31/2009 | E-125-2008/0 | | Monoclonal Antibodies That React With the Capsule of Bacillus anthracis |
| 8/14/2009 | E-063-2009/0 | | Antigen Mixtures for Serological Detection of HHV-8 Infection |
| 8/11/2009 | E-010-1994/0 | 5,610,060 | Isolated Helicobacter hepaticus |
| 7/14/2009 | E-249-2007/0 | 7,678,569 | A Unique Infectious Hepatitis C Virus Clone, Strain HC-TN (genotype 1a) |
| 6/1/2009 | E-093-2000/0 | 6,905,822
7,547,519 | Method of Diagnosing Multidrug Resistant Tuberculosis |
| 12/1/2008 | E-029-2007/0 | | A Varicella-Zoster Virus Mutant that is Markedly Impaired for Latent Infection Available for the Development of Shingles Vaccines and Diagnostics |
| 12/1/2008 | E-228-2002/0 | | Methods and Compositions for Selectively Enriching Microbes |
| 10/1/2008 | E-145-2004/3 | 7,914,788
8,404,818 | Monoclonal Antibodies Against Orthopoxviruses |
| 9/1/2008 | E-123-2007/0
E-146-2004/0 | 8,071,100 | Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF) |
| 9/1/2008 | E-268-2002/0 | 7,261,900
8,394,387 | Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines |
| 9/1/2008 | E-109-2007/1 | 8,216,788 | A Rapid Ultrasensitive Assay for Detecting Prions Based on the Seeded Polymerization of Recombinant Normal Prion Protein (rPrP-sen) |
| 9/1/2008 | E-032-2008/0 | | Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax |
| 8/1/2008 | E-141-2003/0 | 7,993,647 | Monoclonal Antibodies to HIV-1 Vpr |
| 6/1/2008 | E-298-2007/0 | | Immunostimulatory Combinations of TLR Ligands and Methods of Use |
| 10/1/2007 | E-263-2005/0 | 8,252,550 | Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections |
| 6/1/2007 | E-300-2002/0 | | Development of a Novel High Throughput Assay to Measure Cell-Infection with Vaccinia Strains Expressing Reporter Genes |
| 11/1/2006 | E-091-1999/0 | 2259657
6,617,103 | HSV-2 Diagnostic |
| 11/1/2005 | E-104-2005/1 | | Furin Inhibitors and Alpha-Defensin for Preventing Papilloma Virus Infection |
| 11/1/2005 | E-051-2005/0 | | Identification of a Fusion/Entry Receptor for Human Herpesvirus-8 |
| 9/1/2005 | E-184-2004/0 | | A Novel Amplification Method Permits Pathogens to be Detected with Microarrays |
| 8/1/2005 | E-318-2000/0 | | Method for Determining Sensitivity to a Bacteriophage |
| 6/1/2005 | E-238-2003/0 | | Detection and Identification of Mycobacterium Using SecA |
| 4/1/2005 | E-022-2005/0 | | Methods for High-Efficiency Single Genome Sequencing of HIV |
| 4/1/2005 | E-176-2003/0 | | Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria |
| 12/1/2004 | E-004-2005/0
E-004-2005/4 | 7,988,971 | Human Monoclonal Antibodies Against Hendra and Nipah Viruses |
| 12/1/2004 | E-299-2004/0 | | Vaccines Against Crimean-Congo Hemorrhagic Fever |
| 6/1/2004 | E-228-2003/1
E-228-2003/2 | | Soluble SARS Coronavirus Spike Protein (S Protein) |
| 1/1/2004 | E-041-2004/0 | | Codon-Optimization of the HIV-1 Vif Gene |
| 1/1/2004 | E-324-2003/0 | | Streptococcus Lipoprotein Antigens |
| 12/1/2003 | E-276-2003/0 | | HIV-Dependent Expression Vector |
| 11/1/2003 | E-086-1999/0 | 6,875,855
7,332,167 | Molecular Diagnosis of Disseminated Candida albicans Infection Using Hemoglobin-Response Gene |
| 11/1/2003 | E-223-2002/0 | | Factors That Bind Intestinal Toxins |
| 9/1/2003 | E-150-1994/0 | 5,622,861 | Hepatitis A Virus Receptor And Methods Of Use |
| 1/1/2003 | E-144-2002/0
E-144-2002/1 | 7,566,451
7,803,913
8,110,192 | vel Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Selected from Fab Phage Display Libraries Using a Novel Strategy Based on Alternative Antigen Panning
and
Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Single-Chain Antibodies Derived from X5 by DNA Shuffling and Alternating Antigen Panning |
| 1/1/2002 | E-064-2001/0 | 6,951,761 | Parallel Measurements of Multiple Macromolecules Using a Cryoarray |
| 11/1/2001 | E-304-1998/0 | | Recombinant Proteins of the Swine Hepatitis E Virus and Their Uses as a Vaccine and Diagnostic Reagents for Medical and Veterinary Applications |
| 9/1/2001 | E-179-2001/0 | | Identification of a Cell-surface Receptor for Papillomaviruses |
| 2/1/2001 | E-082-1996/0 | | Simian-Human HAV Chimeras Encoding a Hepatitis A Virus Having a Chimeric 2C Protein |
| 4/1/2000 | E-200-1993/0
E-200-1993/1 | 6,039,957
6,171,596 | Oligomeric HIV-1 Envelope Glycoproteins |
| 2/1/1999 | E-034-1989/0 | | Probe To Identify Enteroinvasive E. coli And Shigella Species |
| 9/1/1998 | E-141-1992/2 | | Recombinant Proteins Of A Pakistani Strain Of Hepatitis E And Their Use In Diagnostic Methods And Vaccines |
| 7/1/1998 | E-276-1988/1 | 5,674,720 | Design And Construction Of Non-Infectious Human Retroviral Mutants Deficient In Genomic RNA |
| 3/1/1998 | E-209-1997/0 | 6,600,030 | Delayed Progression To AIDS By A Missense Allele Of The CCR2 Gene |
| 3/1/1998 | E-087-1997/0 | | STRL33, A Human Fusion Accessory Factor Associated With HIV Infection |
| 10/1/1997 | E-056-1990/1 | 5,780,041 | Antigenic Protein Of Borrelia Burgdorferi |
| 10/1/1997 | E-059-1990/0 | 6,709,811 | Versatile Reagent For Detecting Murine Leukemia Viruses |
| 5/1/1997 | E-019-1993/0 | | Parvovirus B19 Receptor And Parvovirus B19 Detection |
| 4/1/1996 | E-454-1986/3 | 5,604,093
6,018,027
6,054,283
RE38824 | Human B Lymphotropic Virus (HBLV) Isolation And Products |
| 5/1/1995 | E-134-1994/0 | | Hepatitis C Virus Core Peptide For Stimulation Of Cytotoxic T Lymphocytes |
| 5/1/1995 | E-032-1994/0 | 5,882,852
7,070,790 | Nucleotide And Deduced Amino Acid Sequences Of The Envelope-1 And Core Genes Of Isolates Of Hepatitis C Virus And Methods Of Use |
| 11/1/1994 | E-325-1983/2 | | Production Of Complementary DNA Representing Hepatitis A Viral Sequences By Recombinant DNA Methods And Uses Therefor |
| 2/1/1994 | E-032-1990/1 | | Method For Immune Capture And Primary Isolation Of Borrelia Burgdorferi |
| 2/1/1994 | E-226-1989/0 | | Specific And Sensitive Diagnostic Test For Lyme Disease |
| 1/1/1994 | E-253-1993/0 | 5,709,996
5,716,620
5,744,142
5,756,284
5,871,998
5,985,610 | Self-Assembling Recombinant Papillomavirus Capsid Proteins |